You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

ESCLIM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Esclim patents expire, and when can generic versions of Esclim launch?

Esclim is a drug marketed by Women First Hlthcare and is included in one NDA.

The generic ingredient in ESCLIM is estradiol. There are seventy-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the estradiol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Esclim

A generic version of ESCLIM was approved as estradiol by BARR LABS INC on October 22nd, 1997.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ESCLIM?
  • What are the global sales for ESCLIM?
  • What is Average Wholesale Price for ESCLIM?
Summary for ESCLIM
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 109
Patent Applications: 4,130
DailyMed Link:ESCLIM at DailyMed
Drug patent expirations by year for ESCLIM

US Patents and Regulatory Information for ESCLIM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-001 Aug 4, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-004 Aug 4, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-002 Aug 4, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-003 Aug 4, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-005 Aug 4, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ESCLIM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-004 Aug 4, 1998 ⤷  Sign Up ⤷  Sign Up
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-001 Aug 4, 1998 ⤷  Sign Up ⤷  Sign Up
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-005 Aug 4, 1998 ⤷  Sign Up ⤷  Sign Up
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-003 Aug 4, 1998 ⤷  Sign Up ⤷  Sign Up
Women First Hlthcare ESCLIM estradiol SYSTEM;TRANSDERMAL 020847-002 Aug 4, 1998 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ESCLIM

See the table below for patents covering ESCLIM around the world.

Country Patent Number Title Estimated Expiration
Germany 3866408 ⤷  Sign Up
European Patent Office 0288336 SELF-STICKING DEVICE FOR THE TRANSDERMAL ADMINISTRATION OF AN ACTIVE AGENT ⤷  Sign Up
France 2612785 ⤷  Sign Up
Portugal 87029 PROCESSO PARA A PREPARACAO DE UM DISPOSITIVO AUTO-ADESIVO PARA ADMINISTRACAO DE UM PRINCIPIO ACTIVO POR VIA PERCUTANEA ⤷  Sign Up
Greece 3003887 ⤷  Sign Up
Austria 69724 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ESCLIM

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1453521 300814 Netherlands ⤷  Sign Up PRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
0398460 12/2004 Austria ⤷  Sign Up PRODUCT NAME: DROSPIRENON IN KOMBINATION MIT ESTRADIOL; NAT. REGISTRATION NO/DATE: 1-25178, 1-25179 20031127; FIRST REGISTRATION: NL RVG 27505 20021211
0136011 2000C/027 Belgium ⤷  Sign Up PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124
0136011 99C0003 Belgium ⤷  Sign Up PRODUCT NAME: ESTRADIOL AND NORETHISTERONE; FIRST REGISTRATION NO/DATE: 403 IS 106 F3 19980928; FIRST REGISTRATION: SE 14007 19980306
0770388 PA2009004,C0770388 Lithuania ⤷  Sign Up PRODUCT NAME: ESTRADIOLI VALERAS + DIENOGESTUM; NAT. REGISTRATION NO/DATE: LT/1/09/1512/001, 2009 04 06 LT/1/09/1512/002, 2009 04 06 LT/1/09/1512/003 20090406; FIRST REGISTRATION: BE 327792 20081103
0398460 04C0022 France ⤷  Sign Up PRODUCT NAME: ESTRADIOL ANHYDRE DROSPIRENONE; REGISTRATION NO/DATE IN FRANCE: NL 28661 DU 20040316; REGISTRATION NO/DATE AT EEC: RVG 27505 DU 20021211
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.